413 related articles for article (PubMed ID: 23193075)
1. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
Mallinckrodt CH; Lin Q; Molenberghs M
Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
[TBL] [Abstract][Full Text] [Related]
2. A structured approach to choosing estimands and estimators in longitudinal clinical trials.
Mallinckrodt CH; Lin Q; Lipkovich I; Molenberghs G
Pharm Stat; 2012; 11(6):456-61. PubMed ID: 22962024
[TBL] [Abstract][Full Text] [Related]
3. A local influence sensitivity analysis for incomplete longitudinal depression data.
Shen S; Beunckens C; Mallinckrodt C; Molenberghs G
J Biopharm Stat; 2006 May; 16(3):365-84. PubMed ID: 16724491
[TBL] [Abstract][Full Text] [Related]
4. Analyzing incomplete longitudinal clinical trial data.
Molenberghs G; Thijs H; Jansen I; Beunckens C; Kenward MG; Mallinckrodt C; Carroll RJ
Biostatistics; 2004 Jul; 5(3):445-64. PubMed ID: 15208205
[TBL] [Abstract][Full Text] [Related]
5. Handling of missing data in long-term clinical trials: a case study.
Janssens M; Molenberghs G; Kerstens R
Pharm Stat; 2012; 11(6):442-8. PubMed ID: 22888095
[TBL] [Abstract][Full Text] [Related]
6. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
Salim A; Mackinnon A; Christensen H; Griffiths K
Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
[TBL] [Abstract][Full Text] [Related]
7. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes.
Wood AM; White IR; Hillsdon M; Carpenter J
Int J Epidemiol; 2005 Feb; 34(1):89-99. PubMed ID: 15333619
[TBL] [Abstract][Full Text] [Related]
8. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation.
Carpenter JR; Roger JH; Kenward MG
J Biopharm Stat; 2013; 23(6):1352-71. PubMed ID: 24138436
[TBL] [Abstract][Full Text] [Related]
9. Intent-to-treat analysis for longitudinal studies with drop-outs.
Little R; Yau L
Biometrics; 1996 Dec; 52(4):1324-33. PubMed ID: 8962456
[TBL] [Abstract][Full Text] [Related]
10. A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trials.
Ayele BT; Lipkovich I; Molenberghs G; Mallinckrodt CH
J Biopharm Stat; 2014; 24(2):211-28. PubMed ID: 24605966
[TBL] [Abstract][Full Text] [Related]
11. An analytic method for the placebo-based pattern-mixture model.
Lu K
Stat Med; 2014 Mar; 33(7):1134-45. PubMed ID: 24122822
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of overall treatment effect in MMRM.
Song T; Dong Q; Sankoh AJ; Molenberghs G
J Biopharm Stat; 2013; 23(6):1281-93. PubMed ID: 24138432
[TBL] [Abstract][Full Text] [Related]
13. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
Yang X; Shoptaw S
Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
[TBL] [Abstract][Full Text] [Related]
14. Estimating the effect of multiple imputation on incomplete longitudinal data with application to a randomized clinical study.
Fong DY; Rai SN; Lam KS
J Biopharm Stat; 2013; 23(5):1004-22. PubMed ID: 23957512
[TBL] [Abstract][Full Text] [Related]
15. Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial.
Habteab Ghebretinsae A; Molenberghs G; Dmitrienko A; Offen W; Sethuraman G
J Biopharm Stat; 2014; 24(3):660-84. PubMed ID: 24697817
[TBL] [Abstract][Full Text] [Related]
16. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
Wei L
J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
[TBL] [Abstract][Full Text] [Related]
17. A latent-class mixture model for incomplete longitudinal Gaussian data.
Beunckens C; Molenberghs G; Verbeke G; Mallinckrodt C
Biometrics; 2008 Mar; 64(1):96-105. PubMed ID: 17608789
[TBL] [Abstract][Full Text] [Related]
18. Accounting for dropout bias using mixed-effects models.
Mallinckrodt CH; Clark WS; David SR
J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
Salim A; Mackinnon A; Griffiths K
Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
[TBL] [Abstract][Full Text] [Related]
20. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
Yang M; Maxwell SE
Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
